Advertisement
DIA
Drug Information Association Logo

Meetings & Training

DIA’s comprehensive educational portfolio reflects and advances innovation in the pharmaceutical, biotechnology, medical device, and related fields and facilitates open dialogue among key professionals from industry, government, academia, and patient organizations.

Find Meetings & Training 

Name Start Date Credits Format Region Location
Clinical Investigator: Module 2 - Conducting the Study Apr 25, 2015 ACPE, CME Online Instruction North America Online
Clinical Investigator: Module 1 - Study Preparation and Initiation Apr 25, 2015 ACPE, CME Online Instruction North America Online
Informed Consent Apr 25, 2015 ACPE Online Instruction North America Online
Crisis Management Apr 25, 2015 ACPE, IACET Online Instruction North America Online
Database Management Apr 25, 2015 ACPE, IACET Online Instruction North America Online
Literature Evaluation Apr 25, 2015 ACPE, IACET Online Instruction North America Online
Literature Searching Apr 25, 2015 ACPE, IACET Online Instruction North America Online
Medical Inquiries Apr 25, 2015 ACPE, IACET Online Instruction North America Online
Medical Writing Apr 25, 2015 IACET Online Instruction North America Online
Product Labeling Apr 25, 2015 ACPE, IACET Online Instruction North America Online
Regulatory Issues Apr 25, 2015 ACPE, IACET Online Instruction North America Online
Statistics for Medical Communications Professionals Apr 25, 2015 ACPE, IACET Online Instruction North America Online
Expert Reactor Panel: IOM Report on Sharing Clinical Trial Data Apr 25, 2015 Online Instruction Global Online
Novel Data Sources: The Positive Impact of Social Media and Online Networks for Engaging with Patients Apr 25, 2015 Online Instruction Global Online
Generic Drug Labeling Proposed Rule and Safety Updates Apr 25, 2015 Online Instruction Global Online
FDA’s Evolving Position on the Brief Summary and Adequate Directions for Use Guidance Apr 25, 2015 Online Instruction Global Online
Target Product Profile – Strategies to Optimize Drug Development, Product Labeling, and Commercialization Apr 25, 2015 Online Instruction Global Online
GVP Module IX Compliant Signal Management Systems in Pharmacovigilance: A Tale of Two Experiences Apr 25, 2015 Online Instruction Global Online
Complimentary Webinar - Using Revolutionary Machine Learning to Find the Most Relevant Content to Drive Informed Decisions in Regulatory Intelligence Apr 25, 2015 Online Instruction Global Online
The Role of the Clinical Data Manager Apr 25, 2015 Online Instruction Global Online
Implementation of the FDASIA Patient Provisions Apr 25, 2015 Online Instruction Global Online
Complimentary: Regulatory and Real World Evidence Challenges of Rare Diseases and Orphan Drugs Apr 25, 2015 Online Instruction Global Online
Variations in the European Union: CMC/Quality Changes Apr 25, 2015 Online Instruction Global Online
Proarrhythmia Apr 25, 2015 Online Instruction Global Online
Facets of Drug-Induced Kidney Injury and Regulatory Perspective Apr 25, 2015 Online Instruction Global Online
Impact on Drug Development of Novel Translational Safety Biomarkers for Improved Detection of Drug-Induced Acute Kidney Injury Apr 25, 2015 Online Instruction Global Online
Pharmacovigilance and Risk Management: Patient Perspective Apr 25, 2015 Online Instruction Global Online
Drug Safety Regulatory Requirements Apr 25, 2015 ACPE, IACET Online Instruction Global Online
Premarketing Clinical Trial Safety Apr 25, 2015 ACPE, IACET Online Instruction Global Online
Postmarketing Safety Management Apr 25, 2015 ACPE, IACET Online Instruction Global Online
Basics of Signal Detection and Pharmacoepidemiology Apr 25, 2015 ACPE, IACET Online Instruction Global Online
Safety Audits and Inspections Apr 25, 2015 ACPE, IACET Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 1: Fundamentals of Clinical Pharmacology: Pharmacokinetics Apr 25, 2015 Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 2: Fundamentals of Clinical Pharmacology: Pharmacodynamics Apr 25, 2015 Online Instruction Global Online
Pharmacovigilance and Global Harmonization Updates Apr 25, 2015 Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology For Drug Development - Part 3: Principles of Modeling and Simulation Apr 25, 2015 Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 4: Determining the Safe First Human Dose Apr 25, 2015 Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 5: Assessment of QT Prolongation Apr 25, 2015 Online Instruction Global Online
Designed for Success: Utilizing Protocol Quality by Design (QbD) to Plan Clinical Studies Apr 25, 2015 Online Instruction Global Online
Negotiation and Influence Apr 25, 2015 Online Instruction Global Online
Introduction to Drug Safety Apr 25, 2015 ACPE, IACET Online Instruction Global Online
How to Prepare for a Safety Inspection Apr 25, 2015 Online Instruction Global Online
Implementation and Status of Periodic Benefit-Risk Evaluation Reporting (PBRER) in Canada Apr 25, 2015 Online Instruction Global Online
Clinical Statistics for Nonstatisticians Apr 25, 2015 Online Instruction Global Online
Advanced Clinical Statistics for Nonstatisticians Apr 25, 2015 Online Instruction Global Online
Development of a Clinical Study Report Apr 25, 2015 Online Instruction Global Online
Art of Writing a Clinical Overview Apr 25, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 6: Preclinical Toxicology & Safety Apr 25, 2015 Online Instruction Global Online
Complimentary - Need to Reinvent the Clinical Trial? Innovate, Collaborate & Integrate Apr 25, 2015 Online Instruction Global Online
Complimentary Webinar - How to Cut Clinical Trial Timelines in Half Apr 25, 2015 Online Instruction Global Online
Disruptive Innovation in Medical Information Apr 25, 2015 Online Instruction Global Online
A Tour of FDA Apr 25, 2015 Online Instruction Global Online
A Tour of Health Canada Apr 25, 2015 Online Instruction Global Online
A Tour of Health Europe Apr 25, 2015 Online Instruction Global Online
Aspects of Regulatory History Apr 25, 2015 Online Instruction Global Online
Bioresearch Monitoring Program (BIMO): Introduction Apr 25, 2015 Online Instruction Global Online
The Clinical Development Process: Investigational Product, Plan, and Data Management Apr 25, 2015 Online Instruction Global Online
Ethical Review Boards Apr 25, 2015 Online Instruction Global Online
Ethics as the Foundation to Clinical Research Apr 25, 2015 Online Instruction Global Online
Awareness of FDA Inspections for Pharmaceutical Manufacturers Apr 25, 2015 Online Instruction Global Online
Biotechnology: An Overview of Compliance Considerations Apr 25, 2015 Online Instruction Global Online
Change Control Apr 25, 2015 Online Instruction Global Online
Clinical Trial Audits and Consequences of Non-Compliance Apr 25, 2015 Online Instruction Global Online
Computerized Systems Inspections in the Medical Device Industry Apr 25, 2015 Online Instruction Global Online
European Union Clinical Trials Directive Apr 25, 2015 Online Instruction Global Online
GMP Principals of SOPs Apr 25, 2015 Online Instruction Global Online
GMP Updates - Enforcement Changes at the New FDA Apr 25, 2015 Online Instruction Global Online
GMPs for API Bulk Manufacturers Apr 25, 2015 Online Instruction Global Online
Good Clinical Practices (GCPs) for New Product Investigations Apr 25, 2015 Online Instruction Global Online
Good Laboratory Practices (GLPs) Apr 25, 2015 Online Instruction Global Online
GxPs Apr 25, 2015 Online Instruction Global Online
HIPAA - The Impact on Clinical Research Apr 25, 2015 Online Instruction Global Online
Introduction to GMPs Apr 25, 2015 Online Instruction Global Online
Investigational Product Development Apr 25, 2015 Online Instruction Global Online
ISO 14155: Obligations of Sponsors and Monitors for Medical Device Trials Apr 25, 2015 Online Instruction Global Online
Key Concepts of Process Validation Apr 25, 2015 Online Instruction Global Online
Laboratory Specimens for Clinical Research Apr 25, 2015 Online Instruction Global Online
Medical Device Safety Reporting Apr 25, 2015 Online Instruction Global Online
Orientation to GMP Compliance Apr 25, 2015 Online Instruction Global Online
Overview of the Clinical Research Process Apr 25, 2015 Online Instruction Global Online
Part 11: Electronic Records and Signatures - Application Apr 25, 2015 Online Instruction Global Online
Part 11: Electronic Records; Electronic Signatures Apr 25, 2015 Online Instruction Global Online
Principles of Good Documentation Apr 25, 2015 Online Instruction Global Online
Protection of Human Subjects in Clinical Trials Apr 25, 2015 Online Instruction Global Online
Selecting and Managing Clinical Contract Research Organizations (CROs) Apr 25, 2015 Online Instruction Global Online
Understanding Post-Approval Changes Apr 25, 2015 Online Instruction Global Online
Computerized Systems Inspections in the Pharmaceutical Industry Apr 25, 2015 Online Instruction Global Online
Basics of the PhRMA Code Apr 25, 2015 Online Instruction Global Online
Basics of AdvaMed Code Apr 25, 2015 Online Instruction Global Online
Eucomed Guidelines on Interactions with Healthcare Professionals Apr 25, 2015 Online Instruction Global Online
Introduction to Medical Device Health Care Compliance Apr 25, 2015 Online Instruction Global Online
Foreign Corrupt Practices Act Apr 25, 2015 Online Instruction Global Online
Global Anti-bribery Apr 25, 2015 Online Instruction Global Online
Variations to Marketing Authorisation in Europe Apr 25, 2015 Online Instruction Global Online
Registration of Monoclonal Antibodies Apr 25, 2015 Online Instruction Global Online
How to Gain Approval to Market a Generic Medicinal Product in the USA Apr 25, 2015 Online Instruction Global Online
Pharmacokinetics and Pharmacodynamics in Drug Registration Apr 25, 2015 Online Instruction Global Online
Implementing Risk-Based Monitoring: Practical Approaches Apr 25, 2015 Online Instruction Global Online
Complimentary - Innovative Strategies for Developing Safer Cancer Therapies Apr 25, 2015 Online Instruction Global Online
Complimentary - Risk-Based Monitoring: Regulatory Expectation and Operational Application Apr 25, 2015 Online Instruction Global Online
Fundamentals of Project Management for Nonproject Managers Apr 25, 2015 Online Instruction Global Online
Planning and Managing Your Projects Apr 25, 2015 Online Instruction Global Online
Team Building and Development Apr 25, 2015 Online Instruction Global Online
Preparing a Clinical Trial Budget Apr 25, 2015 Online Instruction Global Online
Postmarketing Requirements: The Legal Framework, How They Are Issued, Sponsor Obligations and Challenges to Overcome Apr 25, 2015 Online Instruction Global Online
Introduction to the European Union Institutions and Regulatory Authority Apr 25, 2015 Online Instruction Global Online
Introduction to US Institutions and Regulatory Authority (FDA) Apr 25, 2015 Online Instruction Global Online
Introduction to Japanese Institutions and Regulatory Authorities Apr 25, 2015 Online Instruction Global Online
Overview of the CTD and eCTD Apr 25, 2015 Online Instruction Global Online
Introduction to the International Conference on Harmonisation (ICH) Apr 25, 2015 Online Instruction Global Online
The Regulatory Development of a Drug Apr 25, 2015 Online Instruction Global Online
Basics of Clinical Trials Apr 25, 2015 Online Instruction Global Online
How to Register Medicinal Products through the Centralized Procedure Apr 25, 2015 Online Instruction Global Online
How to Register Medicinal Products through the Mutual Recognition Procedure Apr 25, 2015 Online Instruction Global Online
How to Maintain Marketing Approvals in Europe for Centrally Authorised Products Apr 25, 2015 Online Instruction Global Online
How to Register a New Drug in the USA Apr 25, 2015 Online Instruction Global Online
How to Register Medicinal Products through the Decentralized Procedure Apr 25, 2015 Online Instruction Global Online
Access to Unapproved Drugs through Compassionate Use Apr 25, 2015 Online Instruction Global Online
Regulatory Requirements for the Conduct of Clinical Trials in Europe Apr 25, 2015 Online Instruction Global Online
Orphan Drugs in the USA, European Union, and Japan Apr 25, 2015 Online Instruction Global Online
Regulatory Requirements for the Submission of Investigational New Drug Applications in the USA (INDs) Apr 25, 2015 Online Instruction Global Online
Meeting Opportunities with Regulatory Agencies Apr 25, 2015 Online Instruction Global Online
Complementary - How New Electronic Trial Master File (eTMF) Data Standards Can Enhance Clinical Trial Efficiency and Quality Apr 25, 2015 Online Instruction Global Online
Complimentary - Regulatory Solutions in the Cloud - 10 Questions You Can't Afford NOT to Ask Apr 25, 2015 Online Instruction Global Online
Clinical Trials Transparency 3-Part Series: Moving the Debate Forward - Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 1 - Paving the Way for Greater Access To Data Apr 25, 2015 Online Instruction Global Online
Clinical Trials Transparency 3-Part Series: Moving the Debate Forward-Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 2-Connecting the Research Community: Data Sharing–Perspectives from Academia and Patient Advocacy Groups Apr 25, 2015 Online Instruction Global Online
Complimentary - From the Clinic to the CFO: Adaptive Trials and Financial Decision-Making Apr 25, 2015 Online Instruction Global Online
Adverse Event Reporting Requirements: IND and Postmarketing Apr 25, 2015 Online Instruction Global Online
Complimentary - The Affiliate Challenge – How to Improve Compliance and Efficiency when Working with Regional Affiliates Apr 25, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 1: Overall Challenge: The Vision of Better Medicines for Children Apr 25, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 3: Regulatory Framework EU Apr 25, 2015 Online Instruction Global Online
Seven-Part Pediatric Drug Development Webinar Series - Part 4: Dosing in Children Apr 25, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 2: Regulatory Framework US Overview Apr 25, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 5: Technical Development: Pediatric Formulations Apr 25, 2015 Online Instruction Global Online
Basics of the IND Apr 25, 2015 Online Instruction Global Online
Basics of the NDA Apr 25, 2015 Online Instruction Global Online
Regulatory Aspects of Prescription Drug/Biologics Advertising and Promotional Labeling Apr 25, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 7: Operational Challenges of Pediatric Clinical Trials Apr 25, 2015 Online Instruction Global Online
Supplements and Other Changes to an Approved Application Apr 25, 2015 Online Instruction Global Online
Clinical Trials Transparency 3 Part Webinar Series - Part 3: Understanding the Legislation Landscape: Regulatory Updates from the FDA, EMA and Health Canada Apr 25, 2015 Online Instruction Global Online
FDA’s Evolving Position on the Brief Summary and Adequate Directions for Use Guidance Apr 28, 2015 IACET Online Instruction Global Online
Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum Apr 29, 2015 ACPE, IACET In-Person Instruction North America Washington, DC, United States
Basics of the IND Phase May 4, 2015 IACET Online Instruction Global Online
Oversight of Clinical Monitoring: Trends and Strategies May 5, 2015 IACET Online Instruction Global Online
Tutorial #1 – IDMP? What is that and how do I get started? May 11, 2015 In-Person Instruction North America Philadelphia, PA, United States
eRegulatory and Intelligence Annual Conference May 11, 2015 Meetings North America Philadelphia, PA, United States
eRegulatory and Intelligence Virtual Conference May 11, 2015 Meetings Global
Complimentary Webinar - Next Generation Feasibility: Better Planning Through Simulation May 13, 2015 Online Instruction Global Online
Electronic Submissions: The Next Era of Electronic Submissions May 14, 2015 IACET In-Person Instruction North America Philadelphia, PA, United States
Basics of the NDA Phase May 18, 2015 IACET Online Instruction Global Online
Postmarketing Requirements: The Legal Framework, How They Are Issued, Sponsor Obligations and Challenges to Overcome May 19, 2015 ACPE, IACET Online Instruction Global Online
Tutorial 1: PBRERs May 20, 2015 In-Person Instruction North America Toronto, ON, Canada
DIA Canadian Pharmacovigilance & Risk Management Meeting May 21, 2015 IACET Meetings North America Toronto, ON, Canada
How to Prepare for a Safety Inspection Jun 1, 2015 IACET Online Instruction Global Online
#20: The Sunshine Act: Understanding the Essentials of Compliance Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#21: Leadership: How to Organize and Lead People in a Work Group Jun 14, 2015 IACET, PMI In-Person Instruction North America Washington, DC, United States
#22: Successful Drug Development: Best Practices for Clinical Trial Design, Agency Interactions, and Regulatory Document Writing Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
#23: How to Prepare for an FDA Inspection Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#24: Pharmacogenomics and Companion Diagnostics: The Future of Clinical Trials, New Product Development and the Practice of Medicine Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#25: Signal Detection: Identifying and Managing Safety Signals Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
DIA 2015 51st Annual Meeting: Develop. Innovate. Advance. Jun 14, 2015 ACPE, CME, IACET, RN, PMI Meetings North America Washington, DC, United States
#40: Analysis of Safety Data from Clinical Trials Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#41: Quality Oversight of CROs-Clinical Vendors Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
#42: Fundamentals of ANDA Submissions and FDA Expectations Under GDUFA Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#43: Clinical Statistics for Nonstatisticians Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#44: Risk Management and Safety Communication Strategies Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#45: The Good Pharmacovigilance Practices in the EU: Global Applications Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#30: Japan Regulatory Environment: Overview of the Organization, Processes, Systems, and Changes Affecting Pharmaceutical Development Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
#31: Preparing for a US FDA Advisory Committee Meeting Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
#32: Influencing Culture, Avoiding Bureaucracy, and Encouraging Innovation Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
#33: Large-Scale Regulatory Functional Outsourcing: Emerging Trends, Challenges, and Decision Criteria Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
#34: Preparation of Risk Evaluation and Mitigation Strategies Assessment Reports Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
#35: Ethical Issues in Clinical Trials Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
Adverse Event Reporting Requirements: IND and Post-marketing Jul 13, 2015 IACET Online Instruction Global Online
Interactions with the FDA during IND/NDA Phases Jul 16, 2015 Online Instruction Global Online
Global Regulatory Strategy and Drug Development in Asia-Pacific, Latin America and Other Emerging Markets Aug 3, 2015 In-Person Instruction North America Washington, DC, United States
Development of a Clinical Study Report Aug 10, 2015 IACET In-Person Instruction North America Boston, MA, United States
Regulatory Affairs: The IND, NDA, and Postmarketing Aug 10, 2015 IACET In-Person Instruction North America Boston, MA, United States
Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum Aug 10, 2015 ACPE, IACET In-Person Instruction North America Boston, MA, United States
Clinical Project Management Aug 24, 2015 IACET, PMI In-Person Instruction North America Washington, DC, United States
New Drug Product Development and Life Cycle Management Aug 26, 2015 IACET, PMI In-Person Instruction North America Washington, DC, United States
Overview of Drug Development in Japan Sep 2, 2015 Online Instruction Global Online
DIA/FDA Oligonucleotide-Based Therapeutic Conference 2015 Sep 9, 2015 Meetings North America Washington, DC, United States
Patient Engagement in Benefit-Risk Assessment throughout the Life Cycle of Medical Products Sep 17, 2015 Meetings North America North Bethesda, MD, United States
Drug and Device Combination Products – Current Topics Sep 28, 2015 Meetings North America Bethesda, MD, United States
Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum Sep 28, 2015 ACPE, IACET In-Person Instruction North America Toronto, ON, Canada
Clinical Statistics for Nonstatisticians Sep 28, 2015 ACPE, IACET In-Person Instruction North America Washington, DC, United States
Companion Diagnostics Sep 30, 2015 Meetings North America Bethesda, MD, United States
Introduction to Signal Detection and Data Mining Oct 5, 2015 IACET Online Instruction Global Online
Biosimilars Oct 19, 2015 Meetings North America Bethesda, MD, United States
Risk Management and Safety Communication Oct 26, 2015 ACPE, IACET In-Person Instruction North America Washington, DC, United States
DIA Annual Canadian Meeting 2015 Oct 27, 2015 Meetings North America Ottawa, ON, Canada
DIA Annual Canadian Meeting 2015 Call for Abstracts Oct 27, 2015 Meetings North America Ottawa, ON, Canada
Postmarketing Drug Safety & Pharmacovigilance Nov 9, 2015 ACPE, IACET In-Person Instruction North America Philadelphia, PA, United States
Regulatory Affairs: The IND, NDA, and Postmarketing Nov 9, 2015 IACET In-Person Instruction North America Philadelphia, PA, United States
Navigating Chemistry, Manufacturing and Controls Through the Drug Development Process Nov 9, 2015 IACET In-Person Instruction North America Philadelphia, PA, United States
Advanced Clinical Statistics for NonStatisticians Nov 11, 2015 ACPE, IACET In-Person Instruction North America Philadelphia, PA, United States